Artemis Therapeutics Inc. filed its 10-K on Mar 03, 2022 for the period ending Dec 31, 2021. In this report its auditor, Brightman Almagor Zohar & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -25.00% | -25.00% | -58.33% |
1st Jan change | Capi. | |
---|---|---|
-58.33% | 3.36M | |
+5.41% | 111B | |
+12.23% | 105B | |
-12.59% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.87% | 16.96B | |
+5.15% | 13.7B | |
+37.45% | 12.45B |
- Stock Market
- Equities
- MNKA Stock
- News Manuka, Inc.
- Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt